ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,867, issued on Jan. 20, was assigned to Momenta Pharmaceuticals Inc. (Cambridge, Mass.).
"FCRN antibody compositions" was invented by Zhongli Zhang (Cambridge, Mass.), Michael Shifrin (Cambridge, Mass.), Nathaniel J. Washburn (Cambridge, Mass.), Aneta Liwosz (Cambridge, Mass.) and Nasir Khan (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure pertains to compositions comprising an anti-FcRn antibody, M281. The compositions include the full, intact antibody and size variants thereof that not include two antibody heavy chains and to antibody light chains. Thus, a M281 pharmaceutical composition can include: an antibody com...